Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

Clinical trial NCT06532084 · RECRUITING

Trial details

NCT number: NCT06532084
Sponsor: St. Petersburg State Pavlov Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia, in Relapse Myelodysplastic Syndromes Chronic Myeloid Leukemia Myeloproliferative Neoplasm

Start date: 2024-05-22
Primary completion: 2027-05-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.